Record Display for the EPA National Library Catalog

RECORD NUMBER: 11 OF 169

OLS Field Name OLS Field Data
Main Title Arsenic and Antimony Removal from Drinking Water by Adsorptive Media. U.S. EPA Demonstration Project at South Truckee Meadows General Improvement District (STMGID), NV Interim Evaluation Report.
Author Cumming, L. J. ; Wang, L. ; Chen, A. S. C. ;
CORP Author Battelle, Columbus, OH.;National Risk Management Research Lab., Cincinnati, OH. Water Supply and Water Resources Div.
Publisher Aug 2007
Year Published 2007
Report Number EPA/600/R-07/081;
Stock Number PB2008-100161
Additional Subjects Adsorptive media ; Drinking water ; Arsenic removal ; Antimony removal ; Water pollution control ; Water treatment technology ; Demonstration projects ; Operators skills ; Reliability ; Environmental Protection Agency ; Heavy metals ; South Truckee Meadows General Improvement District (STMGID) ; Washoe County (Nevada) ; Granular ferric hydroxide (GFH) ; Maximum contaminant levels (MCLs)
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB2008-100161 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. NTIS 07/09/2008
Collation 63p
Abstract
This report documents the activities performed during and the results obtained from the first 32 weeks of operation of an arsenic and antimony removal technology currently being demonstrated at the South Truckee Meadows General Improvement District (STMGID) in Washoe County, NV. The objectives of the project are to evaluate (1) the effectiveness of a granular ferric hydroxide (GFH) adsorptive media system in removing arsenic and antimony to meet the respective maximum contaminant levels (MCLs) of 10 and 6 ig/L, (2) the reliability of the treatment system, (3) the required system operation and maintenance (O&M) and operators skills, and (4) the capital and O&M cost of the technology. The project also characterizes the water in the distribution system and process residuals produced by the treatment system.